juvabis.ch valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home |
| Description | Bringing to patients life-saving, best-in-class therapies against bacterial Search this site Skip to navigation Home Team Contact News Imprint Home Team Contact News Imprint More Home Team Contact News Imprint Bringing to patients |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 188.114.96.2 |
| Location | Spain |
Related Websites
| Site | Rank |
More to Explore
juvabis.ch Valuation
|
US$495,951
Last updated: 2023-05-17 13:13:10
juvabis.ch has Semrush global rank of 21,341,469. juvabis.ch has an estimated worth of US$ 495,951, based on its estimated Ads revenue. juvabis.ch receives approximately 57,226 unique visitors each day. Its web server is located in Spain, with IP address 188.114.96.2. According to SiteAdvisor, juvabis.ch is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$495,951 |
| Daily Ads Revenue | US$458 |
| Monthly Ads Revenue | US$13,735 |
| Yearly Ads Revenue | US$164,809 |
| Daily Unique Visitors | 3,816 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| juvabis.ch. | A | 300 | IP: 188.114.96.2 |
| juvabis.ch. | A | 300 | IP: 188.114.97.2 |
| juvabis.ch. | AAAA | 300 | IPV6: 2a06:98c1:3120::2 |
| juvabis.ch. | AAAA | 300 | IPV6: 2a06:98c1:3121::2 |
| juvabis.ch. | NS | 21600 | NS Record: ishaan.ns.cloudflare.com. |
| juvabis.ch. | NS | 21600 | NS Record: raina.ns.cloudflare.com. |
| juvabis.ch. | TXT | 300 | TXT Record: google-site-verification=t-C2BiPpNXjiKwtZGRd5li7HLD5p8gTQqH0taQ5lF3U |
HtmlToTextCheckTime:2023-05-17 13:13:10
| Search this site Skip to navigation Home Team Contact News Imprint Home Team Contact News Imprint More Home Team Contact News Imprint Bringing to patients life-saving, best-in-class therapies against bacterial infections. Who is Juvabis? Juvabis is a clinical-stage biopharmaceutical company headquartered in Switzerland. Our best-in-class therapeutic drugs are designed to combat bacterial infections safely and efficiently. We aspire to enable the wonderful advances of modern medicine, supporting the medical community in treating patients worldwide. Best -in-class Antibiotics Juvabis’ “best-in-class” anti-infective drug EBL1003 is currently in clinical trials phase 1. EBL-1003 is designed as an antibiotic-combination therapy for the treatment of critically-ill patients in hospital settings and can be used for common bacterial infections as well as antibiotic-resistant “superbugs”. The drug’s unique design circumvents almost all resistance-mechanisms faced by other competing drugs of its |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 27 Mar 2022 09:11:27 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Sun, 27 Mar 2022 10:11:27 GMT
Location: http://www.juvabis.ch
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=mTHW5r%2F8gTyPSEPr1AlUuMyI0m%2FLoSfDRLms64jh6TqJ0q9g4FxdorAR%2F0z7fWmQXPaxfoNMwzYmtSyAZVJAtD5%2BIcHjZe%2BkKboH5tX0xvGsn9ZSzgwmOtBBLgNeZdX%2BScwejH5QaSsM"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6f26ffaa9b529162-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
HTTP/1.1 301 Moved Permanently
Date: Sun, 27 Mar 2022 09:11:27 GMT
Content-Type: application/binary
Content-Length: 0
Connection: keep-alive
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Pragma: no-cache
Expires: Mon, 01 Jan 1990 00:00:00 GMT
Location: https://www.juvabis.ch/
X-XSS-Protection: 0
X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=zacWZY9JQjb04UsaunV6BnjjwKF8ELfHC7g1%2FiWT%2BswXCL5ZySYKG0H9ZixHDsfhxlEu%2BCiOR6wY26pU0GF9NUxVoVZ4JUixfkh72%2BHCr9QR2ra%2FXe4kJCI0%2Foojun1MsSAGO8V30x93KY%2BXlg%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6f26ffab4ae39bd1-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
HTTP/2 200
date: Sun, 27 Mar 2022 09:11:27 GMT
content-type: text/html; charset=utf-8
x-frame-options: DENY
cache-control: no-cache, no-store, max-age=0, must-revalidate
pragma: no-cache
expires: Mon, 01 Jan 1990 00:00:00 GMT
cross-origin-opener-policy: unsafe-none
content-security-policy: base-uri 'self';object-src 'none';report-uri /_/view/cspreport;script-src 'report-sample' 'nonce-PTUfRJB2A5jmJB6MUb9d5w' 'unsafe-inline' 'unsafe-eval';worker-src 'self';frame-ancestors https://google-admin.corp.google.com/
referrer-policy: strict-origin-when-cross-origin
x-xss-protection: 0
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xJfCBpdSeBt%2ByEsA7pnrg8yfLJH2GndaxqE0TQIjzst%2BHx38Q5o6Fpm2hBeltO9hf2EVy%2F%2FckROk1LlQTAQsYa%2FxnVqXcSSNJPZA8Ipxnh5BMQXoZuOm1%2FjofUkVMDKg14icvWUCeSytjWLKHQ%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6f26ffad5944165a-DME
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
|